Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Simon Beyaert"'
Publikováno v:
Cancers, Vol 13, Iss 23, p 6041 (2021)
In 2019, the FDA approved pembrolizumab, a monoclonal antibody targeting PD-1, for the first-line treatment of recurrent or metastatic head and neck cancers, despite only a limited number of patients benefiting from the treatment. Promising effects o
Externí odkaz:
https://doaj.org/article/9a035ad2a91947e88ced5f83603299a1
Publikováno v:
Critical Issues in Head and Neck Oncology ISBN: 9783031231742
Pembrolizumab and nivolumab, two monoclonal antibodies (mAbs) targeting programmed cell death protein-1 (PD-1), improve the overall survival of patients with inoperable recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e97e48216b3865292be3ff1b54853e67
https://doi.org/10.1007/978-3-031-23175-9_11
https://doi.org/10.1007/978-3-031-23175-9_11
Autor:
Emmanuel Seront, M. Van den Eynde, Thierry Pieters, Anaïs Scohy, Philippe Collard, C. Dumont, F. Aboubakar Nana, A. van der Elst, R. Galot, Jean Cyr Yombi, Frank Cornelis, Simon Beyaert, Marco Gizzi, Ivan Borbath, F. Derouane, A. van Maanen, Filomena Mazzeo, N. Whenham, N. Honoré, François Duhoux, A. De Cuyper, Jean-François Baurain, Bertrand Filleul, I. Sinapi, J.-P. Machiels, C. van Marcke
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC cancer, Vol. 21, no.1, p. 578 [1-12] (2021)
BMC Cancer
BMC cancer, Vol. 21, no.1, p. 578 [1-12] (2021)
BackgroundThe viral pandemic coronavirus disease 2019 (COVID-19) has disrupted cancer patient management around the world. Most reported data relate to incidence, risk factors, and outcome of severe COVID-19. The safety of systemic anti-cancer therap
Autor:
Daniel Langer, Simon Beyaert, Abigail Walker, Sven Seys, Pavol Surda, Caroline Huart, Brecht Steelant, Peter‐Willem Hellings, Mariana Couto, Valérie Hox, Dominique Bullens, Philippe Rombaux
Publikováno v:
Allergy, Vol. 10.1111/all.14786, no.10.1111/all.14786, p. 10.1111/all.14786 (2021)
Allergy: European Journal of Allergy and Clinical Immunology, 76(9), 2716-2729. Wiley-Blackwell
Allergy: European Journal of Allergy and Clinical Immunology, 76(9), 2716-2729. Wiley-Blackwell
Adequate nasal breathing is indispensable for athletes, and nasal symptoms have been shown to interfere with their subjective feeling of comfortable breathing and quality of life. Nasal symptoms are caused by either structural abnormalities or mucosa
Autor:
Nicolas Huyghe, Astrid De Cuyper, Isabelle Sinapi, Fazulur Rehaman Vempalli, Darawan Rinchai, Simon Beyaert, Eleonore Verstraelen, Pierre Goffette, Benoît Ghaye, Mélanie Gilet, Aline Van Maanen, Marie-Laure Castella, Bernhard Mlecnik, Javier Carrasco, Jerome Galon, Davide Bedognetti, Marc Van Den Eynde
Publikováno v:
Journal of Clinical Oncology. 40:3595-3595
3595 Background: Immune checkpoint inhibitors demonstrated poor efficacy in MSS mCRC. Cetuximab (anti-EGFR inhibitor) could initiate, independently from RAS mutation, an immunogenic tumor cell death and mediate antitumor immune response. In this tria
Publikováno v:
Cancers, Vol. 13, no.23, p. 6041 (2021)
Cancers, Vol 13, Iss 6041, p 6041 (2021)
Cancers
Cancers, Vol 13, Iss 6041, p 6041 (2021)
Cancers
Simple Summary Therapeutic vaccines are given to patients with cancer, as opposed to prophylactic vaccines given to a healthy population. The challenge for therapeutic oncological vaccines is to stimulate an immune T cell response against endogenous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6254b6a60560c842b4808d442b85c69
https://hdl.handle.net/2078.1/258788
https://hdl.handle.net/2078.1/258788
Autor:
Bertrand Filleul, N. Whenham, Frank Aboubakar Nana, Philippe Collard, Athénaïs van der Elst, Marco Gizzi, Marc Van den Eynde, Cédric van Marcke, Rachel Galot, Jean Cyr Yombi, Jean-François Baurain, Aline Van Maanen, François Duhoux, Emmanuel Seront, N. Honoré, Jean-Pascal Machiels, Caroline Dumont, I. Sinapi, Simon Beyaert, Françoise Derouane, Thierry Pieters, Anaïs Scohy, Ivan Borbath, Filomena Mazzeo, Astrid De Cuyper, Frank Cornelis
Background The viral pandemic coronavirus disease 2019 (COVID-19) has disrupted cancer patient management around the world. Most reported data relate to incidence, risk factors, and outcome of severe COVID-19. The safety of systemic anti-cancer thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dc34d76771e1dfb437bc000a0947656
https://doi.org/10.21203/rs.3.rs-102553/v1
https://doi.org/10.21203/rs.3.rs-102553/v1
Publikováno v:
Clinical nephrology. 87(5)
BACKGROUND Polyarteritis nodosa (PAN) is a systemic vasculitis involving mainly medium-sized arteries and, rarely, small-sized arteries. The diagnosis is principally based on clinical exams, biopsy of an affected organ, and/or arteriography of renal